iCoreConnect Inc. (ICCT) Stock Analysis

iCoreConnect Inc. (ICCT) Healthcare & Pipeline Overview

iCoreConnect Inc. leverages cloud-based technology to provide HIPAA compliant software solutions for healthcare providers, enhancing operational efficiency and patient care through a comprehensive suite of services tailored to the needs of modern medical practices.

What Is the Investment Thesis for ICCT?

iCoreConnect Inc. operates in a rapidly evolving healthcare technology landscape, with a focus on HIPAA compliant SaaS solutions. The company's gross margin stands at 76.8%, indicating strong profitability potential despite a current profit margin of -289.9%. Key growth catalysts include the increasing demand for electronic health solutions, the expansion of telehealth services, and regulatory pressures for compliance, which are expected to drive adoption of iCoreConnect's products. The healthcare SaaS market is projected to grow significantly, providing iCoreConnect with opportunities to capture market share. However, investors may want to evaluate risks such as competitive pressures and the company's current financial instability, which may impact its ability to scale effectively in the near term.

Based on FMP financials and quantitative analysis

ICCT Key Highlights

Gross margin of 76.8% indicates strong profitability potential.

• Market cap currently stands at $0.00B, reflecting early-stage growth.
• Profit margin of -289.9% highlights the need for operational improvements.
• Beta of -1.55 suggests high volatility relative to the market.
• No dividend yield as the company reinvests in growth initiatives.

Who Are ICCT's Competitors?

ICCT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are ICCT's Key Strengths?

Strong gross margin of 76.8% indicates potential for profitability.

• Comprehensive suite of HIPAA compliant products enhances market appeal.
• Established brand presence and industry experience since 1992.

What Are ICCT's Weaknesses?

Current profit margin of -289.9% highlights financial instability.

• Limited market capitalization may restrict growth opportunities.
• Dependence on a small number of key products for revenue.

What Could Drive ICCT Stock Higher?

Expansion of telehealth services expected to drive revenue growth in the next 1-2 years.

• Increasing demand for HIPAA compliant solutions as healthcare regulations tighten.
• Potential partnerships with major healthcare providers to enhance product adoption.

What Are the Key Risks for ICCT?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

• Intense competition from larger healthcare software providers.
• Financial instability indicated by a negative profit margin.
• Regulatory changes that could impact operational costs and compliance.

What Are the Growth Opportunities for ICCT?

• Expansion of Telehealth Services: The telehealth market is projected to reach $459.8 billion by 2030, driven by increasing demand for remote healthcare solutions. iCoreConnect can leverage its existing software to provide integrated telehealth services, enhancing patient engagement and accessibility while generating additional revenue streams.
• Increased Regulatory Compliance: As healthcare regulations become more stringent, the demand for compliant solutions is expected to rise. iCoreConnect's focus on HIPAA compliance positions it well to capture market share as healthcare providers seek reliable partners to ensure adherence to evolving regulations.
• Integration of AI and Machine Learning: The integration of AI and machine learning in healthcare is set to revolutionize patient care and operational efficiency. iCoreConnect can enhance its product offerings by incorporating AI-driven analytics, providing healthcare providers with actionable insights to improve patient outcomes and streamline administrative processes.
• Partnerships with Healthcare Providers: Forming strategic partnerships with healthcare providers can expand iCoreConnect's reach and enhance its product offerings. Collaborations with larger healthcare systems can lead to increased adoption of its solutions and drive revenue growth through shared resources and expertise.
• Market Penetration in Emerging Markets: As healthcare systems in emerging markets continue to evolve, there is a growing demand for affordable and compliant healthcare solutions. iCoreConnect has the opportunity to expand its services internationally, tapping into new customer bases and diversifying its revenue streams.

What Threats Does ICCT Face?

• Intense competition from established players in the healthcare software market.
• Rapid technological changes may require continuous innovation.
• Regulatory changes could impact operational processes and costs.

What Are ICCT's Competitive Advantages?

• Strong focus on HIPAA compliance differentiates iCoreConnect from competitors.
• Diverse product offerings cater to various needs within the healthcare sector.
• Established reputation in the industry enhances customer trust and loyalty.

What Does ICCT Do?

Founded in 1992, iCoreConnect Inc. is a cloud-based software and technology company headquartered in Ocoee, Florida. Originally known as iMedicor, Inc., the company rebranded to iCoreConnect in June 2017 to reflect its focus on innovative healthcare solutions. iCoreConnect specializes in providing Health Insurance Portability and Accountability Act (HIPAA) compliant software as a service (SaaS) to healthcare providers across the United States. The company’s extensive product lineup includes iCoreRx, an electronic prescription software; iCorePDMP, which checks patients' Prescription Drug Monitoring Program history; and iCoreVerify, a solution for insurance eligibility verification. Additional offerings include iCoreHuddle, which reveals revenue potential for each patient; iCoreCodeGenius, a medical coding reference tool; and iCoreClaims for claims processing. iCoreConnect also provides secure email solutions, cloud backup services, payment processing, and IT managed services. With a workforce of 67 employees, iCoreConnect is positioned to address the growing demand for compliance and efficiency in healthcare operations, offering a comprehensive suite of tools designed to improve patient care and streamline administrative tasks.

What Products and Services Does ICCT Offer?

• Develops cloud-based software solutions for healthcare providers.
• Offers HIPAA compliant electronic prescription software.
• Provides tools for insurance eligibility verification.
• Delivers secure email solutions for healthcare professionals.
• Facilitates patient payment processing and revenue cycle tracking.
• Offers IT managed services to enhance operational efficiency.

How Does ICCT Make Money?

• Generates revenue through subscription fees for its SaaS products.
• Offers tiered pricing models based on the size and needs of healthcare providers.
• Provides additional services such as IT support and consulting for an added fee.

What Industry Does ICCT Operate In?

The healthcare information services industry is experiencing significant growth, driven by the increasing digitization of patient records and the need for compliance with regulations such as HIPAA. The market for healthcare software solutions is expected to expand as providers seek to enhance operational efficiency and improve patient outcomes. iCoreConnect Inc. is well-positioned within this landscape, offering a comprehensive suite of solutions that address both compliance and operational needs. The competitive landscape includes various players, but iCoreConnect's focus on HIPAA compliance and its diverse product offerings provide a unique advantage in meeting the specific needs of healthcare providers.

Who Are ICCT's Key Customers?

• Healthcare providers including hospitals and clinics.
• Pharmacies utilizing electronic prescription services.
• Insurance companies requiring compliance solutions.

iCoreConnect Inc. Financial Trajectory

iCoreConnect Inc. (ICCT) reported $2.1M in revenue for Q4 FY2024, a decline of 23.0% compared to the prior quarter. The company recorded a net loss of $9.5M, with diluted EPS of $-26.14. Revenue has contracted over three consecutive quarters, which investors in this unknown Healthcare stock should monitor closely. Across the four most recent quarters, ICCT averaged $-22.04 in diluted EPS.

Company Profile

iCoreConnect Inc. operates in the Software - Application industry within the Technology sector. It is headquartered in Ocoee, US. The company is led by CEO Robert McDermott. ICCT has traded publicly since 1998.

iCoreConnect Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

The most recent 12 insider filings for iCoreConnect Inc. break down as 4 sales and 8 purchases. On net that is roughly 43K shares disposed (about $62K), a signal worth weighing alongside the fundamentals.

ICCT Financials

ICCT Latest News

What Investors Ask About iCoreConnect Inc. (ICCT) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources